Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Ichiro, Yamauchi"'
Autor:
Takashi Shoji, Ichiro Yamauchi, Hidenori Kawasaki, Kogoro Iwanaga, Takuro Hakata, Daisuke Tanaka, Junji Fujikura, Toshihiko Masui, Hisato Suzuki, Mamiko Yamada, Kenjiro Kosaki, Yosuke Kasai, Etsuro Hatano, Akira Inaba, Takahito Wada, Shinji Kosugi, Yohei Ueda, Toshihito Fujii, Daisuke Taura, Nobuya Inagaki
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Silver-Russell syndrome (SRS) is a syndrome characterized by prenatal and postnatal growth retardation, facial features, and body asymmetry. SRS is often complicated with hypoglycemia, whose etiology is unclear. We describe the clinical course of 25-
Externí odkaz:
https://doaj.org/article/566307c80b1c494997f2f8310beebcf7
Autor:
Ichiro Yamauchi, Takuro Hakata, Taku Sugawa, Daisuke Kosugi, Haruka Fujita, Kentaro Okamoto, Yohei Ueda, Toshihito Fujii, Daisuke Taura, Norio Harada, Nobuya Inagaki
Publikováno v:
Endocrine Journal, Vol 70, Iss 10, Pp 987-998 (2023)
Immune checkpoint inhibitors (ICIs) are used for various malignancies, although they frequently cause immune-related adverse events involving the thyroid gland (thyroid irAEs). We conducted a retrospective cohort study to elucidate thyroid function o
Externí odkaz:
https://doaj.org/article/5377cab0fa8d4a11b42f449e3fa68f31
Autor:
Kentaro Sakaki, Takaaki Murakami, Hiroyuki Fujimoto, Yoichi Shimizu, Kanae Kawai Miyake, Daisuke Otani, Sakura Kiyobayashi, Takuya Okada, Masakazu Fujimoto, Takuro Hakata, Ichiro Yamauchi, Kotaro Shimada, Hironori Shimizu, Kazuyuki Nagai, Yuji Nakamoto, Nobuya Inagaki
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundInsulinomas are the most common functioning pancreatic neuroendocrine neoplasms, and these tumors induce hypoglycemia due to hyperinsulinemia. Hypoglycemia caused by insulinomas can cause seizures, coma or death due to the delayed diagnosis
Externí odkaz:
https://doaj.org/article/3237cc1ca0a0480fb3b0b551073a4ebe
Autor:
Ichiro Yamauchi, Takuro Hakata, Yohei Ueda, Taku Sugawa, Ryo Omagari, Yasuo Teramoto, Shoji F. Nakayama, Daisuke Nakajima, Takuya Kubo, Nobuya Inagaki
Publikováno v:
iScience, Vol 26, Iss 7, Pp 107135- (2023)
Summary: As 3,3′,5-triiodothyroacetic acid (TRIAC), a metabolite of thyroid hormones (THs), was previously detected in sewage effluent, we aimed to investigate exogenous TRIAC’s potential for endocrine disruption. We administered either TRIAC or
Externí odkaz:
https://doaj.org/article/98d3586dcee3471484aa21791263dc6b
Autor:
Yuu Miyazaki, Atsuhiko Ichimura, Ryo Kitayama, Naoki Okamoto, Tomoki Yasue, Feng Liu, Takaaki Kawabe, Hiroki Nagatomo, Yohei Ueda, Ichiro Yamauchi, Takuro Hakata, Kazumasa Nakao, Sho Kakizawa, Miyuki Nishi, Yasuo Mori, Haruhiko Akiyama, Kazuwa Nakao, Hiroshi Takeshima
Publikováno v:
eLife, Vol 11 (2022)
The growth plates are cartilage tissues found at both ends of developing bones, and vital proliferation and differentiation of growth plate chondrocytes are primarily responsible for bone growth. C-type natriuretic peptide (CNP) stimulates bone growt
Externí odkaz:
https://doaj.org/article/91ee6b2baaf9466698b26e41dba695c7
Autor:
Ryo Omagari, Mayuko Yagishita, Fujio Shiraishi, Shoji F. Nakayama, Masanori Terasaki, Tetsuya Tanigawa, Ichiro Yamauchi, Takuya Kubo, Daisuke Nakajima
Publikováno v:
Environmental sciencetechnology. 56(19)
3,3',5-Triiodothyroacetic acid (TRIAC) was identified as a major contributor to the activity of thyroid hormone receptor (TR) agonists in environmental water. TRIAC contributed 60-148% of the TR-agonist activity in effluents from sewage treatment pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2a56333a052de70c2c7c35a32f9cd68
https://pubmed.ncbi.nlm.nih.gov/36100216
https://pubmed.ncbi.nlm.nih.gov/36100216
Autor:
Yohei Ueda, Keisho Hirota, Ichiro Yamauchi, Takuro Hakata, Takafumi Yamashita, Toshihito Fujii, Akihiro Yasoda, Nobuya Inagaki
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240023 (2020)
C-type natriuretic peptide (CNP) is a pivotal enhancer of endochondral bone growth and is expected to be a therapeutic reagent for impaired skeletal growth. Although we showed that CNP stimulates bone growth as a local regulator in the growth plate v
Externí odkaz:
https://doaj.org/article/59f3679a80a14a9dafaef9194910c4f1
Publikováno v:
European Journal of Dermatology. 32:638-640
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a925b2b6771e50fbdc9302f25897e70
https://doi.org/10.1684/ejd.2022.4322
https://doi.org/10.1684/ejd.2022.4322
Autor:
Ichiro Yamauchi, Akihiro Yasoda, Shigemi Matsumoto, Yuichi Sakamori, Young Hak Kim, Motoo Nomura, Atsushi Otsuka, Toshinari Yamasaki, Ryoichi Saito, Morimasa Kitamura, Toshio Kitawaki, Masakatsu Hishizawa, Nobuko Kawaguchi-Sakita, Toshihito Fujii, Daisuke Taura, Masakatsu Sone, Nobuya Inagaki
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0216954 (2019)
BackgroundBlocking the PD-1 pathway induces immune-related adverse events (irAEs) which often involve the thyroid gland (thyroid irAEs). Clinical features of a thyroid irAE including its predictability and relationship to prognosis remain to be eluci
Externí odkaz:
https://doaj.org/article/5af6610dbdcb437fa513957cc5348edd
Autor:
Yoko Ueba, Ichiro Yamauchi, Takuro Hakata, Haruka Fujita, Kentaro Okamoto, Kaori Ikeda, Yohei Ueda, Toshihito Fujii, Daisuke Taura, Nobuya Inagaki
Publikováno v:
Endocrine journal.
Immune checkpoint inhibitors (ICIs) frequently cause immune-related adverse events (irAEs) that often involve endocrine organs. Pembrolizumab and atezolizumab are currently administered in combination with chemotherapy for several malignancies. Altho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab75f88687f38ad877db38d29d84cc27
https://pubmed.ncbi.nlm.nih.gov/36464271
https://pubmed.ncbi.nlm.nih.gov/36464271